Burning Rock Biotech Dividends and Buybacks
Dividend criteria checks 0/6
Burning Rock Biotech does not have a record of paying a dividend.
Key information
n/a
Dividend yield
2.0%
Buyback Yield
| Total Shareholder Yield | 2.0% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
Recent updates
Little Excitement Around Burning Rock Biotech Limited's (NASDAQ:BNR) Revenues
Jun 21
Will Burning Rock Biotech (NASDAQ:BNR) Spend Its Cash Wisely?
Mar 25There's No Escaping Burning Rock Biotech Limited's (NASDAQ:BNR) Muted Revenues
Feb 01Burning Rock Biotech Limited (NASDAQ:BNR) Shares Could Be 24% Below Their Intrinsic Value Estimate
Jul 12Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Deliver On Growth Plans?
Apr 28We Think Burning Rock Biotech (NASDAQ:BNR) Needs To Drive Business Growth Carefully
Dec 23Is Burning Rock Biotech (NASDAQ:BNR) In A Good Position To Invest In Growth?
Sep 20Burning Rock Biotech GAAP EPS of -$0.37 misses by $0.01, revenue of $19.5M misses by $2.94M
Aug 31Burning Rock Localizes As Investors Grow Impatient
Jun 06We're Hopeful That Burning Rock Biotech (NASDAQ:BNR) Will Use Its Cash Wisely
Mar 24Following Rough Year, Is Burning Rock Set To Turn The Corner?
Nov 17Is Burning Rock Biotech (NASDAQ:BNR) Using Debt In A Risky Way?
Aug 27A Look At The Intrinsic Value Of Burning Rock Biotech Limited (NASDAQ:BNR)
Jul 23Is Burning Rock Biotech (NASDAQ:BNR) Using Debt Sensibly?
May 13Burning Rock Biotech Expands Test Portfolio In Bid For Growth
Dec 30Burning Rock inks license pact with Oncocyte Corporation
Dec 15Burning Rock Biotech prices upsized offering of 2.243M ADSs at $25.75/ADS
Dec 04Burning Rock Biotech EPS misses by $0.08, beats on revenue
Nov 20Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if BNR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BNR's dividend payments have been increasing.
Dividend Yield vs Market
| Burning Rock Biotech Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (BNR) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.3% |
| Industry Average (Biotechs) | 2.3% |
| Analyst forecast (BNR) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate BNR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BNR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate BNR's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as BNR has not reported any payouts.